A new non-invasive approach using urinary AIT-EVs for the diagnosis of membranous nephropathy
-
-
REFERENCES
[1] Sethi S., Beck L.H., Jr., Glassock R.J., et al. (2023). Mayo Clinic consensus report on membranous nephropathy: Proposal for a novel classification. Kidney Int. 104:1092−1102. DOI:10.1016/j.kint.2023.06.032 [2] Beck L.H., Jr., Bonegio R.G., Lambeau G., et al. (2009). M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 361:11−21. DOI:10.1056/NEJMoa0810457 [3] Ronco P., Beck L., Debiec H., et al. (2021). Membranous nephropathy. Nat. Rev. Dis. Primers 7:69. DOI:10.1038/s41572-021-00303-z [4] Lahme K., Sachs W., Froembling S., et al. (2025). Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease. Cell 189:123−142. DOI:10.1016/j.cell.2025.11.010 [5] Hengel F.E., Dehde S., Lassé M., et al. (2024). Autoantibodies targeting nephrin in podocytopathies. N. Engl. J. Med. 391:422−433. DOI:10.1056/NEJMoa2314471 -
ABOUT THIS ARTICLE
Cite this article:
Qi E. and Li X. (2027). A new non-invasive approach using urinary AIT-EVs for the diagnosis of membranous nephropathy. The Innovation Medicine 5:100277. https://doi.org/10.59717/j.xinn-med.2027.100277
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Qi E. and Li X. (2027). A new non-invasive approach using urinary AIT-EVs for the diagnosis of membranous nephropathy. The Innovation Medicine 5:100277. https://doi.org/10.59717/j.xinn-med.2027.100277
Format
Content
DownLoad:
-
Figure 1.
A new non-invasive approach using urinary AIT-EVs for the diagnosis of membranous nephropathy
